Current Issue:
April 8, 2004
|
|
|
|
News, events, features |
|
Science/Research |
|
Latest
scientific findings |
|
|
|
The people behind the university |
|
|
|
Harvard and neighbor communities |
|
|
|
Scores, highlights, upcoming games |
|
|
| Newsmakers,
notes, students, police log |
|
|
|
Museums, concerts, theater |
|
|
|
Two-week listing of upcoming events |
 |
|
Gazette headlines delivered to your desktop |
|
|
|
April 8, 2004
|
Straight to the heart of the matter
Christopher Cannon of Harvard Medical School has led the first study to prove that major reductions in cholesterol result in major reductions in death and severe heart attacks. The study used the highest available dose of the statin drug Lipitor. (Staff photo Kris Snibbe/Harvard News Office) Full story
|
|
HARVARD GAZETTE ARCHIVES
High-dose drugs prevent heart deaths
Outperform standard medications
Dana-Farber Cancer Institute launches Center for Applied Cancer Science to expedite cancer drug discovery and development
Use of guns by teens for threats more likely than for self-defense
Armed confrontation between adolescents is typical context for self-defense gun use
Newly identified gene linked to brain development
Discovery of GPR56 sheds light on evolution of frontal lobes
'Women Healing Women' gather at Harvard Divinity School
Wide range of faith traditions, healing styles come together
Reanalysis finds mammograms save lives
Statistics team from Harvard, Berkeley, and Kaiser Permanente counters earlier critique
|
